BRUNELLI, CLAUDIO
 Distribuzione geografica
Continente #
EU - Europa 26.632
AS - Asia 2.637
NA - Nord America 1.562
SA - Sud America 214
AF - Africa 58
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 31.110
Nazione #
IT - Italia 26.172
US - Stati Uniti d'America 1.468
SG - Singapore 1.164
CN - Cina 677
VN - Vietnam 462
FR - Francia 204
BR - Brasile 133
HK - Hong Kong 94
BD - Bangladesh 60
FI - Finlandia 55
AR - Argentina 46
DE - Germania 45
CA - Canada 37
GB - Regno Unito 37
CH - Svizzera 34
MX - Messico 34
JP - Giappone 32
IN - India 30
IQ - Iraq 20
NL - Olanda 18
ZA - Sudafrica 14
PH - Filippine 13
ID - Indonesia 12
CL - Cile 10
KR - Corea 10
PK - Pakistan 10
EC - Ecuador 9
IE - Irlanda 9
KE - Kenya 9
CO - Colombia 8
RU - Federazione Russa 8
CR - Costa Rica 7
EG - Egitto 7
JM - Giamaica 7
TH - Thailandia 7
UA - Ucraina 7
PL - Polonia 6
TN - Tunisia 6
UZ - Uzbekistan 6
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
ES - Italia 4
LT - Lituania 4
SA - Arabia Saudita 4
SE - Svezia 4
TR - Turchia 4
CI - Costa d'Avorio 3
JO - Giordania 3
MA - Marocco 3
PA - Panama 3
VE - Venezuela 3
AL - Albania 2
AO - Angola 2
AT - Austria 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BW - Botswana 2
DZ - Algeria 2
GA - Gabon 2
GT - Guatemala 2
IL - Israele 2
IR - Iran 2
LB - Libano 2
LU - Lussemburgo 2
MN - Mongolia 2
MT - Malta 2
MY - Malesia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PE - Perù 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
CZ - Repubblica Ceca 1
GE - Georgia 1
GN - Guinea 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LC - Santa Lucia 1
MR - Mauritania 1
NE - Niger 1
NP - Nepal 1
PT - Portogallo 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
Totale 31.106
Città #
Genova 15.923
Genoa 5.887
Rapallo 2.534
Vado Ligure 1.666
San Jose 571
Singapore 568
Lauterbourg 193
Ashburn 163
Ho Chi Minh City 147
Hanoi 115
Beijing 105
New York 92
Hong Kong 86
Bordighera 60
Helsinki 53
Santa Clara 52
Council Bluffs 49
Los Angeles 36
Frankfurt am Main 34
Zurich 34
Orem 29
Tokyo 29
Mexico City 22
Da Nang 21
Tianjin 20
Haiphong 15
Amsterdam 14
Chennai 13
Dallas 12
São Paulo 12
Montreal 9
Baghdad 8
Dublin 8
Johannesburg 8
London 8
Nairobi 8
Toronto 8
Biên Hòa 7
Chicago 7
Guangzhou 7
Manchester 7
Milan 7
Phoenix 7
Rome 7
San José 7
Denver 6
Memphis 6
Nuremberg 6
Warsaw 6
Buffalo 5
Cardiff 5
Curitiba 5
Guarulhos 5
Houston 5
Hải Dương 5
Naples 5
Poplar 5
Quito 5
Quảng Ngãi 5
San Francisco 5
Tunis 5
Atlanta 4
Boardman 4
Brescia 4
Buenos Aires 4
Can Tho 4
Charlotte 4
Chongqing 4
City of London 4
Huntington 4
Kingston 4
Kyiv 4
Marseille 4
Mumbai 4
Philadelphia 4
Phú Thọ 4
Queens 4
Stockholm 4
Tashkent 4
Abidjan 3
Bari 3
Bắc Ninh 3
Cairo 3
Campinas 3
Columbus 3
Córdoba 3
Des Moines 3
Durban 3
Empoli 3
Florianópolis 3
Fortaleza 3
Jakarta 3
Lahore 3
Madrid 3
Ottawa 3
Panama City 3
Phú Nhuận 3
Phủ Lý 3
Quilmes 3
Seattle 3
Totale 28.887
Nome #
5-fluorouracil causes endothelial cell senescence: Potential protective role of glucagon-like peptide 1 264
Advanced Oxidation Protein Products-Modified Albumin Induces Differentiation of RAW264.7 Macrophages into Dendritic-Like Cells Which Is Modulated by Cell Surface Thiols. 238
Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytes 234
Neurohormonal activation and pharmacological inhibition in pulmonary arterial hypertension and related right ventricular failure 233
Acute coronary syndromes do not promote prolonged in vivo FXII-dependent prothrombotic activity 230
Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions. 230
Cell-cell bond modulates vascular smooth muscle cell responsiveness to Angiotensin II 229
The vulnerable coronary plaque: update on imaging technologies. 227
Update on cardiotoxicity of anti-cancer treatments 221
The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicity 219
CD16+ monocyte subsets are increased in large abdominal aortic aneurysms and are differentially related with circulating and cell-associated biochemical and inflammatory biomarkers. 210
Distinguishing ventricular septal bulge versus hypertrophic cardiomyopathy in the elderly 208
Thrombin induces protease-activated receptor 1 signaling and activation of human atrial fibroblasts and dabigatran prevents these effects 205
Myostatin mediates abdominal aortic atherosclerosis progression by inducing vascular smooth muscle cell dysfunction and monocyte recruitment 203
Data regarding the effects of thrombin and dabigatran-inhibited thrombin on protease-activated receptor 1 and activation of human atrial fibroblasts 201
Anterior mitral valve aneurysm is an uncommon complication of aortic valve infective endocarditis: A case report 200
Anorexia nervosa and heart disease: a systematic review 199
ALTERED CELL-FUNCTION ASSOCIATED TO LOSS OF CELL-MATRIX ADHESION: PRELIMINARY DATA ON A RAT AORTIC SMOOTH MUSCLE CELL LINE 197
Detection of the "Crossed Aorta Sign" during Echocardiography before Angiography 196
C242T polymorphism in CYBA gene (p22phox) and risk of coronary artery disease in a population of Caucasian Italians 195
Cardiovascular effects of antimuscarinic agents and beta3-adrenergic receptor agonist for the treatment of overactive bladder 193
Comparison of coronary flow reserve estimated by dynamic radionuclide SPECT and multi-detector x-ray CT 193
Clinical characteristics and prognostic impact of atrial fibrillation in patients with chronic heart failure 192
Moderate increase of indoxyl sulfate promotes monocyte transition into profibrotic macrophages 192
Cardiovascular effects of antimuscarinic agents in overactive bladder 191
Resveratrol counteracts systemic and local inflammation involved in early abdominal aortic aneurysm development 191
Evaluation of growth hormone administration in patients with chronic heart failure secondary to coronary artery disease 190
Aberrant Right Subclavian Artery (Arteria Lusoria) Challenging 4-French Homolateral Transradial Coronary Catheterisation in Adulthood 190
Prevalent cardiac, renal and cardiorenal damage in patients with advanced abdominal aortic aneurysms 189
Perfusional and metabolic effects of nisoldipine as shown by positron emission tomography after acute myocardial infarction 186
Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2 186
Urgent cesarean delivery following a spontaneous coronary artery dissection 186
Alzheimer's Disease and Cardiovascular Disease: A Particular Association 183
Brachial Artery Endothelial-dependent Flow-mediated Dilation Identifies Early-stage Endothelial Dysfunction in Systemic Sclerosis and Correlates with Nailfold Microvascular Impairment 182
Testosterone Antagonizes Doxorubicin-Induced Senescence of Cardiomyocytes 180
Increased neutrophil lifespan in patients with congestive heart failure. 179
Frequency, predictors and prognostic impact of implantable cardioverter defibrillator shocks in a primary prevention population with heart failure and reduced ejection fraction 179
Sublethal Doses of an Anti-erbB2 Antibody Leads to Death by Apoptosis in Cardiomyocytes Sensitized by Low Prosenescent Doses of Epirubicin: The Protective Role of Dexrazoxane. 178
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. 177
N-acetyl-cysteine reduces neointimal thickening and procoagulant activity after balloon-induced injury in abdominal aortae of NewZealand white rabbits 177
Associazione tra lipoperossidazione ed insorgenza giovanile di aterosclerosi coronarica. 176
Recurrent and residual shunts after patent foramen ovale closure: Results from a long-term transcranial doppler study 176
Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure 176
An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline 175
CYBA polymorphism associated with oxidative stress in Italian patients with early onset of coronary artery disease. 174
Acute myocardial infarction related to very late sirolimus-eluting stent thrombosis 6 months after discontinuation of dual antiplatelet therapy 174
Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis 173
Protective effects of Resveratrol in an experimental model of abdominal aortic aneurysm induction. 170
Glibenclamide Mimics Metabolic Effects of Metformin in H9c2 Cells 170
Arterial hypertension in cancer: The elephant in the room 170
The need of developing selective prediction models in elderly patients with heart failure 169
EFFECTS OF RAMIPRIL ON CARDIOVASCULAR AND MICROVASCULAR OUTCOMES IN PEOPLE WITH DIABETES MELLITUS: RESULTS OF THE HOPE STUDY AND MICRO-HOPE SUBSTUDY 168
Maximal endothelial tissue plasminogen activator release is not impaired in patients with acute coronary syndromes before heparin treatment. 168
Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia 168
Early contribution of arterial wave reflection to left ventricular relaxation abnormalities in a community-dwelling population of normotensive and untreated hypertensive men and women. 165
Clinical Characteristics and Long-Term Mortality Rate in Female Patients with Takotsubo Syndrome Compared with Female Patients with ST-Elevation Acute Myocardial Infarction: A Retrospective Study from a Single Center 165
Biophysical aspects and novel treatments of atrial fibrillation 165
The relationship between visceral adiposity and left ventricular diastolic function: results from the Baltimore Longitudinal Study of Aging. 164
Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure. 163
Association between plasma insulin and angiographically documented significant coronary artery disease. 163
Methods, accuracy and clinical implications of atrial fibrillation detection by cardiac implantable electronic devices 163
Sudden death after valve-in-valve procedure due to delayed coronary obstruction: A case report 163
An evaluation of the pharmacokinetics and pharmacodynamics of ivabradine for the treatment of heart failure 162
Ivabradine in Cancer Treatment-Related Left Ventricular Dysfunction 162
Role of advanced oxidation protein products and Thiol ratio in patients with acute coronary syndromes 161
Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients 161
An Emerging Cardiovascular Disease: Takotsubo Syndrome 161
Carvedilol prevents mitochondrial membrane potential loss induced by doxorubicin in cardiomyocytes 160
Inhibition of Doxorubicin-Induced Senescence by PPARδ Activation Agonists in Cardiac Muscle Cells: Cooperation between PPARδ and Bcl6. 160
Update on the efficacy of statin treatment in Acute Coronary Syndromes. 159
Cyba polymorphism associated to oxidative stress in italian patients with early onset coronary artery disease. 4th meeting of the ETRO working party on population genetics of haemostatic risk factors for arterial vascular disease 158
ADVANCED ABDOMINAL AORTIC ANEURYSMS DISPLAY ASPECIFIC INFLAMMATORY-PROATHEROSCLEROTIC PROFILEWITH RENAL DYSFUNCTION, RAISED D-DIMER, EXPANDEDCD14++CD16+-MONOCYTES HAVING HIGH CD143 157
Incidence and clinical relevance of primary congenital anomalies of the coronary arteries in children and adults. 156
Attivazione del fattore coagulativo XII in pz con angina stabile ed instabile 154
BASSE DOSI DI DOXORUBICINA PORTANO I CARDIOMIOCITI A MORTE TARDIVA PER CATASTROFE MITOTICA DOVUTA AD UNA ALTERATA REGOLAZIONE DELLE PROTEINE DEL TELOMERO: RUOLO DELLE MAPKs E DI p53 153
Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case. 153
Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetes 152
Thrombolysis in refractory unstable angina. 151
Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness 151
Controllo antagonista di p38 e JNK nella regolazione della senescenza e di p16INK4A indotte dalla doxorubicina nei progenitori delle cellule endoteliali 151
Predictors of cardiovascular outcome and rehospitalization in elderly patients with heart failure 151
Myostatin: A Playmaker in Chronic Kidney Disease and Vascular Damage 150
SOLUBLE FORM OF THE ENDOTHELIAL ADHESION MOLECULECD146 BINDS PREFERENTIALLY PROINFLAMMATORYPROATHEROSCLEROTICCD16+ MONOCYTE SUBSET 149
Brachial artery endothelial-dependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with naifold microvascular impairment 146
Autoanticorpi contro proteine ossidate in pazienti con recente sviluppo di angina instabile. 146
Early Age of onset of unstable angina is associated to major oxidative stress 146
Contribution of central adiposity to left ventricular diastolic function (from the Baltimore Longitudinal Study of Aging). 146
Comparison between the potential protective mechanisms of carvedilol and atenolol against doxorubicin induced cardiac muscle cell damage and death in vitro. 145
HETEROGENEITY AND DIFFERENT RELATIONSHIP WITH BIOCHEMICAL AND INFLAMMATORY BIOMARKERS FOR THE CIRCULATING CD16+ MONOCYTES SUBSETS IN ABDOMINAL AORTIC ANEURYSMS (AAA) 145
Protective effects of carvedilol against doxorubicin-induced apoptosis in cardiac muscle cells 145
CD14CD16 monocyte subset levels in heart failure patients. 144
Matrix metalloproteinase-2 and-9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase 143
Clinical stabilization of patients with unstable angina treated with thrombolytic therapy. 143
Comprehensive Imaging Assessment of Right Ventricular Strain in Acute Pulmonary Embolism 143
EFFECTS OF AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR, RAMIPRIL, ON CARDIOVASCULAR EVENTS IN HIGH-RISK PATIENTS 142
INFECTIVE ENDOCARDITIS IN HYPERTROPHIC CARDIOMYOPATHY: PREVALENCE, INCIDENCE AND INDICATIONS FOR ANTIBIOTIC PROPHYLAXIS 140
Comparison of clinical presentation, left ventricular morphology, hemodynamics, and exercise tolerance in obese versus nonobese patients with hypertrophic cardiomyopathy. 140
Percutaneous treatment of left main coronary stenosis as a late complication of bentall operation for acute aortic dissection 140
High doses of atorvastatin do not affect activity of prothrombinase in patients with acute coronary syndromes 139
Role of bone mineral density in the inverse relationship between body size and aortic calcification: Results from the Baltimore Longitudinal Study of Aging. 139
Totale 17.475
Categoria #
all - tutte 95.214
article - articoli 85.905
book - libri 955
conference - conferenze 8.085
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 269
Totale 190.428


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021137 0 0 0 0 0 0 0 0 0 0 0 137
2021/20222.754 59 189 197 363 123 193 138 669 102 262 99 360
2022/20232.993 301 201 32 321 558 492 9 248 478 15 301 37
2023/20241.300 48 178 19 159 107 233 78 88 116 23 79 172
2024/20254.055 123 306 126 301 552 421 337 680 158 178 371 502
2025/20266.843 890 158 404 509 837 714 1.276 359 450 762 368 116
Totale 31.391